These findings are particularly relevant given that individuals with MetS often exhibit impaired metabolic flexibility (Smith et al., 2018), compounded by lower baseline FatOx rates, which may reflect underlying mitochondrial inefficiencies or insulin resistance. The gene discussed is INS; the disease is metabolic syndrome.